vs
高乐氏（CLX）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
高乐氏的季度营收约是瑞思迈的3.4倍（$4.8B vs $1.4B），瑞思迈同比增速更快（11.0% vs -6.7%），过去两年高乐氏的营收复合增速更高（62.2% vs 7.8%）
高乐氏是美国跨国企业，专业从事消费级与专业用途产品的生产及营销。2000年至2024年持续入选《财富》500强榜单，最新排名为第485位，旗下产品覆盖清洁护理、家居日用等多个品类，在全球消费市场拥有较高认可度。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CLX vs RMD — 直观对比
营收规模更大
CLX
是对方的3.4倍
$1.4B
营收增速更快
RMD
高出17.7%
-6.7%
两年增速更快
CLX
近两年复合增速
7.8%
损益表 — Q3 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $4.8B | $1.4B |
| 净利润 | — | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | — | 34.6% |
| 净利率 | — | 27.6% |
| 营收同比 | -6.7% | 11.0% |
| 净利润同比 | — | 13.9% |
| 每股收益（稀释后） | — | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLXRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $4.8B | $1.4B | ||
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.8B | $1.2B |
净利润CLXRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | — | $398.7M | ||
| Q4 25 | $157.0M | $392.6M | ||
| Q3 25 | — | $348.5M | ||
| Q2 25 | $332.0M | $379.7M | ||
| Q1 25 | $186.0M | $365.0M | ||
| Q4 24 | $193.0M | $344.6M | ||
| Q3 24 | $99.0M | $311.4M |
毛利率CLXRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | 43.2% | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | 46.5% | 60.8% | ||
| Q1 25 | 44.6% | 59.3% | ||
| Q4 24 | 43.8% | 58.6% | ||
| Q3 24 | 45.8% | 58.6% |
营业利润率CLXRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | 20.6% | 33.7% | ||
| Q1 25 | 15.2% | 33.0% | ||
| Q4 24 | 14.1% | 32.5% | ||
| Q3 24 | 10.0% | 31.6% |
净利率CLXRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | — | 27.9% | ||
| Q4 25 | 9.4% | 27.6% | ||
| Q3 25 | — | 26.1% | ||
| Q2 25 | 16.7% | 28.2% | ||
| Q1 25 | 11.2% | 28.3% | ||
| Q4 24 | 11.4% | 26.9% | ||
| Q3 24 | 5.6% | 25.4% |
每股收益（稀释后）CLXRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | $2.74 | ||
| Q4 25 | $1.29 | $2.68 | ||
| Q3 25 | — | $2.37 | ||
| Q2 25 | $2.68 | $2.58 | ||
| Q1 25 | $1.50 | $2.48 | ||
| Q4 24 | $1.54 | $2.34 | ||
| Q3 24 | $0.80 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | — | $6.3B |
| 总资产 | — | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资CLXRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | $227.0M | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $167.0M | $1.2B | ||
| Q1 25 | $226.0M | $932.7M | ||
| Q4 24 | $290.0M | $521.9M | ||
| Q3 24 | $278.0M | $426.4M |
总债务CLXRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | $2.5B | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益CLXRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $-125.0M | $6.3B | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | $321.0M | $6.0B | ||
| Q1 25 | $27.0M | $5.5B | ||
| Q4 24 | $-41.0M | $5.3B | ||
| Q3 24 | $60.0M | $5.2B |
总资产CLXRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $5.6B | $8.5B | ||
| Q3 25 | — | $8.3B | ||
| Q2 25 | $5.6B | $8.2B | ||
| Q1 25 | $5.5B | $7.6B | ||
| Q4 24 | $5.6B | $7.1B | ||
| Q3 24 | $5.5B | $7.2B |
负债/权益比CLXRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | 7.74× | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | $637.0M | — |
| 自由现金流率自由现金流/营收 | 13.3% | — |
| 资本支出强度资本支出/营收 | 2.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLXRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $339.7M | ||
| Q3 25 | — | $457.3M | ||
| Q2 25 | $294.0M | $538.8M | ||
| Q1 25 | $286.0M | $578.7M | ||
| Q4 24 | $180.0M | $308.6M | ||
| Q3 24 | $221.0M | $325.5M |
自由现金流CLXRMD
| Q2 26 | — | — | ||
| Q1 26 | $637.0M | — | ||
| Q4 25 | — | $311.2M | ||
| Q3 25 | — | $414.4M | ||
| Q2 25 | $219.0M | $508.2M | ||
| Q1 25 | $233.0M | $557.9M | ||
| Q4 24 | $127.0M | $288.0M | ||
| Q3 24 | $182.0M | $307.7M |
自由现金流率CLXRMD
| Q2 26 | — | — | ||
| Q1 26 | 13.3% | — | ||
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | 11.0% | 37.7% | ||
| Q1 25 | 14.0% | 43.2% | ||
| Q4 24 | 7.5% | 22.5% | ||
| Q3 24 | 10.3% | 25.1% |
资本支出强度CLXRMD
| Q2 26 | — | — | ||
| Q1 26 | 2.5% | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | 3.8% | 2.3% | ||
| Q1 25 | 3.2% | 1.6% | ||
| Q4 24 | 3.1% | 1.6% | ||
| Q3 24 | 2.2% | 1.5% |
现金转化率CLXRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.87× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | 0.89× | 1.42× | ||
| Q1 25 | 1.54× | 1.59× | ||
| Q4 24 | 0.93× | 0.90× | ||
| Q3 24 | 2.23× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
